APA (7th ed.) Citation

Neda Anastassova, Denitsa Aluani, Nadya Hristova-Avakumova, Virginia Tzankova, Magdalena Kondeva-Burdina, Miroslav Rangelov, . . . Denitsa Yancheva. (2022). Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson's Disease. MDPI AG.

Chicago Style (17th ed.) Citation

Neda Anastassova, Denitsa Aluani, Nadya Hristova-Avakumova, Virginia Tzankova, Magdalena Kondeva-Burdina, Miroslav Rangelov, Nadezhda Todorova, and Denitsa Yancheva. Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson's Disease. MDPI AG, 2022.

MLA (9th ed.) Citation

Neda Anastassova, et al. Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson's Disease. MDPI AG, 2022.

Warning: These citations may not always be 100% accurate.